Arun A. Gupta

Synthesis and antidiabetic activity of 2,5-disubstituted-3-imidazol-2-yl-pyrrolo[2,3-b]pyridines and thieno[2,3-b]pyridines

Rajesh Bahekar, Mukul R. Jain, Pradip Jadav et al. · Bioorganic & Medicinal Chemistry · 2007 · 93 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8

Design, synthesis, and biological evaluation of substituted-N-(thieno[2,3-b]pyridin-3-yl)-guanidines, N-(1H-pyrrolo[2,3-b]pyridin-3-yl)-guanidines, and N-(1H-indol-3-yl)-guanidines

Rajesh Bahekar, Mukul R. Jain, Ashish Goel et al. · Bioorganic & Medicinal Chemistry · 2007 · 69 citations

Pharmacy, Chemistry, Medicinal Chemistry +12

Synthesis and Antidiabetic Activity of 3,6,7‐Trisubstituted‐2‐(1<i>H</i>‐imidazol‐2‐ylsulfanyl)quinoxalines and Quinoxalin‐2‐yl isothioureas

Rajesh Bahekar, Mukul R. Jain, Arun A. Gupta et al. · Archiv der Pharmazie · 2007 · 39 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

A computationally designed binding mode flip leads to a novel class of potent tri-vector cyclophilin inhibitors

Alessio De Simone, C. Georgiou, Harris Ioannidis et al. · Chemical Science · 2018 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +17

Interaction of the S100A6 mutant (C3S) with the V domain of the receptor for advanced glycation end products (RAGE)

Sepuru K. Mohan, Arun A. Gupta, Chin Yu · Biochemical and Biophysical Research Communications · 2013 · 35 citations

Life Sciences, Biochemistry, Molecular Biology +6